Quarterly report pursuant to Section 13 or 15(d)

Borrowings (Details)

v3.20.2
Borrowings (Details) - USD ($)
3 Months Ended 9 Months Ended
May 18, 2020
Mar. 09, 2020
Jan. 23, 2020
Sep. 30, 2020
Sep. 30, 2020
Feb. 06, 2020
Apr. 18, 2019
Issuance of common stock and warrants, net of offering costs (in shares) 60,250            
Warrant exercisable for shares of common stock           4,553 12,756
Funding Agreement | Convertible debt              
Principal amount of debt     $ 111,100        
Original issue discount     10.00%        
Issuance of common stock and warrants, net of offering costs (in shares)     500        
Term of warrant exercisable     5 years        
Warrant exercisable for shares of common stock     7,936        
Exercise price of warrants     $ 9.80        
Consideration     $ 100,000        
Period of execution of funding agreement   45 days          
Interest expense from amortization of debt discounts       $ 0 $ 20,000